Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18226326 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)(COMPLETED)
Condition: Atherosclerosis
Interventions: Drug: ezetimibe (+) simvastatin;   Drug: simvastatin;   Drug: atorvastatin

Indicates status has not been verified in more than two years